Key Takeaways Procter & Gamble posted 1% y/y sales growth in Q2, with strength in Beauty and Health Care.Colgate delivered 2.2% y/y organic sales growth in Q2, driven by pricing and oral care leadership.CL's 2026 estimates show faster EPS growth, while PG trades below its 5-year median P/E.In the global consumer staples arena, The Procter & Gamble Company (PG) and Colgate-Palmolive Company (CL) represent two distinct models of market leadership. PG operates as a diversified powerhouse, commanding a strong m ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 (State or other jurisdiction of incorporation or organization) 300 Park Avenue ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 1-644 COLGATE-PALMOLIVE COMPANY (Exact name of registrant a ...

Key Takeaways Intellia Therapeutics has surged 57.2% in 12 weeks, outperforming the S&P 500's 5.6% rise.Getty Realty jumped 14.5% since Dec. 24 after being upgraded to a Zacks Rank #2.Colgate-Palmolive gained 20.6% in 12 weeks as part of the ECAP portfolio.Last Friday, the three most widely followed benchmark indexes closed a winning week. The Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average advanced 1.5%, 1.1% and 0.3%, respectively.The rally was driven by improving investor sentiment fol ...

Goldman Sachs maintains a "Buy" rating for NYSE:CL, raising the price target from $94 to $100.The company showcased its strategic initiatives at the Consumer Analyst Group of New York Conference 2026, boosting investor confidence.With a market capitalization of approximately $76.65 billion and a trading volume of 3,562,948 shares, Colgate-Palmolive demonstrates significant market presence and investor interest.Colgate-Palmolive Company (NYSE:CL) is a global leader in consumer products, specializing in oral ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Colgate-Palmolive Company (NYSE:CL) 2026 Conference February 20, 2026 08:00 AM ET Company ParticipantsCaroline Chulick - SVP of Global Growth and InnovationDara Mohsenian - Managing DirectorNoel Wallace - Chairman, President, and CEONone - Video Narrator 1None - Video Narrator 2None - Video Narrator 3None - Video Narrator 4None - Video Narrator 5None - Video Narrator 6Conference Call ParticipantsAndrea Teixeira - Managing Director and Senior Equity Research AnalystModeratorGood morning, everyone, and welcom ...

Consumer Analyst Group of New York Conference February 20, 2026 © 2026 Colgate-Palmolive Company TEAM NAME February 2026 Notice for Investor Presentation Please review the following presentation in conjunction with our fourth quarter and full year 2025 earnings press release, our fourth quarter and full year 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non- GAAP reconciliations, which are available in the Investor Center section of ...

Key Takeaways Colgate delivered record 2025 sales and free cash flow despite raw material inflation and incremental tariffs.Colgate's SGPP aims to streamline operations and fund the 2030 strategy while driving EPS growth.CL expects 2026 margin expansion via pricing, productivity and revenue-management efforts.Colgate-Palmolive Company (CL) entered 2026 with improved momentum after navigating a volatile 2025, marked by raw-material inflation, incremental tariffs and uneven category growth. Despite these pres ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alon ...

Core Insights - Colgate-Palmolive Company is facing challenges in sustaining growth amid muted demand in the consumer staples sector, particularly in developed markets, and is focusing on balancing pricing discipline with volume recovery [1][4] Group 1: Financial Performance - In Q4 2025, Colgate achieved over 3% underlying organic sales growth, despite soft category demand, with global category growth stabilizing at approximately 1.5% to 2.5% [2][7] - For 2026, Colgate is guiding for 1% to 4% organic sales growth, with results heavily reliant on pricing and volume dynamics across different regions [2][7] Group 2: Regional Insights - North America is experiencing negative category volumes, with consumers being cautious and opting for promotions, while Colgate is employing revenue growth management and targeted promotions to remain competitive [3] - In contrast, Latin America and parts of Asia are showing stronger elasticity, allowing Colgate to increase prices while still achieving volume growth [3] Group 3: Strategic Approach - Colgate's strategy emphasizes the importance of pricing to offset costs and fund investments, while long-term growth will depend on volume recovery, especially in mature markets [4] - The company is focusing on a stronger innovation pipeline, premiumization, and data-driven pricing strategies to navigate the current market conditions without damaging brand equity [4] Group 4: Valuation Metrics - Colgate's forward 12-month P/E ratio stands at 24.59X, which is above the industry average of 19.88X and the sector average of 18.24X, indicating a premium valuation that may reflect stronger growth expectations [8]